These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8769155)

  • 1. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 2. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
    Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW
    Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
    [No Abstract]   [Full Text] [Related]  

  • 7. Microchimerism and heart allograft acceptance.
    Masaki Y; Hirasawa A; Okuyama S; Tsujimoto G; Iwaya M; Li XK; Yokoi Y; Nakamura S; Baba S; Miyamoto M
    Transplant Proc; 1995 Feb; 27(1):148-50. PubMed ID: 7878949
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract]   [Full Text] [Related]  

  • 12. Microchimerism and graft acceptance: V. Rat liver allograft acceptance.
    Miyahara T; Yokoi Y; Hara MH; Nakamura S; Baba S; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Iwaya M; Yamaguchi A; Yoshimasu H; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1291-2. PubMed ID: 8658664
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
    Watson CJ; Davies HF; Cobbold SP; Rasmussen A; Rebello PR; Thiru S; Waldmann H; Calne RY; Metcalfe SM
    Transplant Proc; 1995 Feb; 27(1):123-4. PubMed ID: 7878859
    [No Abstract]   [Full Text] [Related]  

  • 14. A short course of cyclosporin A combined with anti-CD4 and/or anti-TCR MAb treatment induces long-term acceptance of kidney allografts in the rat.
    Lácha J; Chadimová M; Havlícková J; Brock J; Matl I; Volk HD; Lehmann M
    Transplant Proc; 1995 Feb; 27(1):125-6. PubMed ID: 7878869
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-CD4 therapy induces a donor-specific, organ-nonspecific tolerance in allogeneic kidney graft recipients.
    Kuttler B; Lehmann M; Lacha J; Brock J; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):728-9. PubMed ID: 8171628
    [No Abstract]   [Full Text] [Related]  

  • 16. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
    Sablinski T; Hancock WW; Schmidbauer G; Milford EL; Kupiec-Weglinski JW
    Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract]   [Full Text] [Related]  

  • 18. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat.
    Ko S; Deiwick A; Jäger MD; Dinkel A; Rohde F; Fischer R; Tsui TY; Rittmann KL; Wonigeit K; Schlitt HJ
    Nat Med; 1999 Nov; 5(11):1292-7. PubMed ID: 10545996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microchimerism and allograft acceptance: is it caused by microchimerism or graft antigens?
    Kimura H; Hua Y; Goto T; Kokubo T; Amemiya H; Suzuki S; Miyamoto M; Tanaka K
    Transplant Proc; 2000 Nov; 32(7):2045-6. PubMed ID: 11120059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.